Clinical trial
Application of mRNA Immunotherapy Technology in EB Virus Related Diseases
NCT07349836 is registered in ClinicalTrials.gov with Xinqiao Hospital of Chongqing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of mRNA Immunotherapy Technology in EB Virus Related Diseases
- Lead sponsor
- Xinqiao Hospital of Chongqing
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- January 10, 2026
- Completion date
- December 31, 2028
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ebv-associated tumors